Brandywine Oak Private Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.65M | Buy |
6,378
+9
| +0.1% | +$9.2K | 0.58% | 28 |
|
|
2026
Q1 | $5.86M | Buy |
6,369
+66
| +1% | +$66.9K | 0.49% | 29 |
|
|
2025
Q4 | $6.77M | Hold |
6,303
| – | – | 0.57% | 28 |
|
|
2025
Q3 | $4.81M | Buy |
6,303
+6
| +0.1% | +$4.46K | 0.42% | 32 |
|
|
2025
Q2 | $4.91M | Sell |
6,297
-39
| -0.6% | -$30.3K | 0.45% | 32 |
|
|
2025
Q1 | $5.23M | Sell |
6,336
-9
| -0.1% | -$7.49K | 0.51% | 30 |
|
|
2024
Q4 | $4.9M | Sell |
6,345
-36
| -0.6% | -$29.8K | 0.48% | 31 |
|
|
2024
Q3 | $5.65M | Sell |
6,381
-159
| -2% | -$143K | 0.55% | 28 |
|
|
2024
Q2 | $5.92M | Sell |
6,540
-344
| -5% | -$275K | 0.61% | 27 |
|
|
2024
Q1 | $5.36M | Sell |
6,884
-52
| -0.7% | -$37K | 0.56% | 28 |
|
|
2023
Q4 | $4.04M | Sell |
6,936
-184
| -3% | -$107K | 0.45% | 33 |
|
|
2023
Q3 | $3.82M | Buy |
7,120
+38
| +0.5% | +$19.6K | 0.45% | 33 |
|
|
2023
Q2 | $3.32M | Buy |
7,082
+3
| +0% | +$1.26K | 0.37% | 38 |
|
|
2023
Q1 | $2.43M | Sell |
7,079
-66
| -0.9% | -$22.3K | 0.28% | 54 |
|
|
2022
Q4 | $2.61M | Sell |
7,145
-357
| -5% | -$127K | 0.33% | 47 |
|
|
2022
Q3 | $2.43M | Buy |
7,502
+243
| +3% | +$77K | 0.33% | 49 |
|
|
2022
Q2 | $2.35M | Buy |
7,259
+153
| +2% | +$45.9K | 0.3% | 53 |
|
|
2022
Q1 | $2.04M | Sell |
7,106
-125
| -2% | -$32.2K | 0.23% | 73 |
|
|
2021
Q4 | $2M | Buy |
7,231
+200
| +3% | +$50.7K | 0.22% | 76 |
|
|
2021
Q3 | $1.62M | Sell |
7,031
-138
| -2% | -$34.1K | 0.19% | 84 |
|
|
2021
Q2 | $1.65M | Buy |
7,169
+484
| +7% | +$97.2K | 0.19% | 83 |
|
|
2021
Q1 | $1.25M | Buy |
6,685
+3
| +0% | +$587 | 0.18% | 82 |
|
|
2020
Q4 | $1.13M | Buy |
6,682
+2
| +0% | +$299 | 0.17% | 85 |
|
|
2020
Q3 | $988K | Sell |
6,680
-17
| -0.3% | -$2.63K | 0.17% | 85 |
|
|
2020
Q2 | $1.1M | Sell |
6,697
-208
| -3% | -$31.9K | 0.2% | 76 |
|
|
2020
Q1 | $957K | Buy |
6,905
+290
| +4% | +$39.8K | 0.2% | 75 |
|
|
2019
Q4 | $869K | Buy |
6,615
+2
| +0% | +$232 | 0.16% | 77 |
|
|
2019
Q3 | $739K | Buy |
6,613
+4,003
| +153% | +$446K | 0.14% | 80 |
|
|
2019
Q2 | $289K | Buy |
2,610
+3
| +0.1% | +$353 | 0.06% | 165 |
|
|
2019
Q1 | $338K | Buy |
2,607
+3
| +0.1% | +$365 | 0.07% | 140 |
|
|
2018
Q4 | $301K | Buy |
+2,604
| New | +$291K | 0.07% | 149 |
|
Other funds holding LLY
Brandywine Oak Private Wealth's LLY Position: Q2 2026 in Review
Brandywine Oak Private Wealth increased its Eli Lilly (LLY) stake by 0.14% in Q2 2026, buying an estimated $9.2K and bringing the position to 6,378 shares worth $7.65M. The position accounts for 0.58% of the portfolio, ranked #28.
Brandywine Oak Private Wealth first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Brandywine Oak Private Wealth held 6,378 shares of Eli Lilly worth $7.65M as of Q2 2026.
- Brandywine Oak Private Wealth bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
- Eli Lilly made up 0.58% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #28 holding.
- Brandywine Oak Private Wealth first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.